PhD, Statistics, Cornell University, 2008
Industry and Consulting Experience
Consultant, Northwestern University School of Medicine, working with Dr. Ruchi Gupta, 6/2016 - present.
Consultant, BEFORE Brands, Inc., working with Ashley Dombkowski and Kari Nadeau from Stanford University School of Medicine, 7/2016 - present.
Chief Operating Officer, Veriflow Systems, Inc., 1/2013 - 2/2016.
Clinical Statistician, Takeda Pharmaceuticals, 6/2008 - 1/2014.
H. Naik, S. Chan, M. Vakilynejad, G. Chen, H. Loft, A.R. Mahableshwarkar, J. Areberg. A Population Pharmacokinetic-Pharmacodynamic Meta-Analysis of Vortioxetine in Patients with Major Depressive Disorder. Basic Clinical Pharmacology and Toxicology, 2015 Nov.
P.L. Jacobsen, L. Harper, L. Chrones, S. Chan, and A.R. Mahableshwarkar. Safety and tolerability of vortioxetine (15 and 20 mg) in subjects with major depressive disorder: results of an open-label, flexible dose, 52-week extension study. International Clinical Psychopharmacology, 2015 Sep;30(5):255-64.
P. Jacobsen, A.R. Mahableshwarkar, M. Serenko, S. Chan, and M.H. Trivedi. A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Vortioxetine 10 mg and 20 mg in Adults with Major Depressive Disorder. J. Journal of Clinical Psychiatry, 2015 May;76(5):575-82.
A.N. Vidyashankar, R.M. Kaplan, and S. Chan. Statistical Approach to Measure the Efficacy of Anthelmintic Treatment on Horse Farms. Parasitology, Volume 134, Issue 14, pp 2027-2039, December 2007.